Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Rosuvastatin Therapy in Hypercholesterolaemic Patients With Coronary Heart Disease Assessed by IVUS
jRCT1080220348Phase 4
- Sponsor
- AstraZeneca
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rosuvastatin in hypercholesterolemia and coronary arteriosclerosis, sponsored by AstraZeneca.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiacoronary arteriosclerosis
Beyond the preview
Go deeper on jRCT1080220348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220348.